H. Shah

Biography

Hemanshu Shah joined Transgene in May 2014. Mr. Shah has more than 25 years’ experience in the pharmaceutical/biotechnology industries in a variety of functional and therapeutic areas, with significant experience in oncology. Prior to joining Transgene, he was Vice President of Global Marketing and Therapeutic Area Head for Infectious Diseases, Transplantation, Immunology and Dermatology at Astellas (2012-2014). Before Astellas, he was Chief Operating Officer at Arog Pharmaceuticals (2010-2011), Chief Business Officer at Innate Pharma (2008-2010) and Vice President of Commercial Operations at GPC Biotech (2003-2008). Hemanshu Shah was Global Commercial Leader for Oncology at Johnson & Johnson (2002-2003) and held a variety of positions of increasing responsibility at Bristol-Myers Squibb (1988-2002). He has a PhD in Pharmaceutical Sciences from Rutgers University and an MBA from SUNY (Buffalo). Hemanshu Shah joined Transgene in May 2014. Mr. Shah has more than 25 years’ experience in the pharmaceutical/biotechnology industries in a variety of functional and therapeutic areas, with significant experience in oncology. Prior to joining Transgene, he was Vice President of Global Marketing and Therapeutic Area Head for Infectious Diseases, Transplantation, Immunology and Dermatology at Astellas (2012-2014). Before Astellas, he was Chief Operating Officer at Arog Pharmaceuticals (2010-2011), Chief Business Officer at Innate Pharma (2008-2010) and Vice President of Commercial Operations at GPC Biotech (2003-2008). Hemanshu Shah was Global Commercial Leader for Oncology at Johnson & Johnson (2002-2003) and held a variety of positions of increasing responsibility at Bristol-Myers Squibb (1988-2002). He has a PhD in Pharmaceutical Sciences from Rutgers University and an MBA from SUNY (Buffalo).

Research Interest

accounting and finance